Supplemental Material Table of Contents
Page No.
Supplemental Table 1. Missing PM
2.51
Supplemental Table 2. Excluded participants 1
Supplemental Table 3. Participants censored 1
Supplemental Table 4. Variable parameterization 2
Supplemental Table 5. Missing covariates 2
Supplemental Table 6. Heterogeneity of effect (I
2) for associations of annual average PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD
3
Supplemental Table 7. Sensitivity analyses for associations of annual average PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD when omitting Jackson and testing 60- and 120-month PM
2.5exposures
4
Supplemental Table 8. Heterogeneity of effect for associations of annual average PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD when excluding Jackson
5
Supplemental Table 9. CKD incidence in participants with estimated glomerular filtration rate
≥ 60 ml/min/1.73 m
2at baseline by site, stratified by median annual average PM
2.56 Supplemental Table 10. Between and within site effects for Cox proportional hazards models
of annual average PM
2.5and incident CKD 7
Supplemental Table 11. Sensitivity analyses for association of annual average PM
2.5with
incident CKD when excluding those with urinary albumin to creatinine ratio ≥ 30 mg/g 8 Supplemental Table 12. Competing risk analysis for association of annual average PM
2.5with
incident CKD with a competing risk of non-CKD death 9
Supplemental Table 13. Positive and negative control models for the associations of annual
average PM
2.5with height, area deprivation index, incident cellulitis, and incident mortality 10 Supplemental Figure 1. Forest plots describing overall and site-specific associations of annual average PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD.
11
Supplemental Figure 2. Forest plots describing overall and site-specific associations of 60- month PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD.
12
Supplemental Figure 3. Forest plots describing overall and site-specific associations of 120- month PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD.
13
Supplemental Table 1. Missing PM
2.5Exposure Number missing (%)
12-month PM2.5 476 (4.1) 60-month PM2.5 580 (5.0) 120-month PM2.5 635 (5.5) Missing any PM2.5 647 (5.6)
Supplemental Table 2. Excluded participants
Population Number
Population with visit 4 creatinine 11,560 Excluded incomplete annual PM2.5 exposure 476
Excluded ESRD at baseline 20
Excluded black in Minneapolis or Washington Co 37
Excluded non-white, non-black 30
Population in cross-sectional analyses 10,997 Excluded eGFR < 60 ml/min/1.73 m2 at baseline 695 Population in CKD incidence analysis 10,302
Supplemental Table 3. Participants censored
Population Number
Total censored 4,780
Deceased 4,277
Lost to follow up 503
Supplemental Table 4. Variable parameterization
Variable Parameterization
Demographic
Sex Female vs non-female
Age Linear
Race Black vs non-black
Mean ambient temperature Linear Socioeconomic
Neighborhood socioeconomic score Linear
Annual family income < $5000, $5000-7999, $8000-11,999, $12,000-15,999, $16,000- 24,999, $25,000-34,999, $35,000-49,999, $50,000-74,999,
$75,000-99,999, ≥ $100,000 Education level ≤ 11 years, 12-16 years, 17-21 years Clinical
Body mass index Linear spline with knot at 30 kg/m2
Smoking status Never, former, current
Estimated glomerular filtration rate Linear
Urinary albumin to creatinine ratio Log-transformed C-reactive protein Log-transformed
Diabetes mellitus Yes vs no
Hypertension Yes vs no
Systolic blood pressure Linear spline with knot at 120 mm Hg Composite cardiovascular disease Yes vs no
Supplemental Table 5. Missing covariates
Covariate Number missing (%)
Female 0 (0.0)
Age 0 (0.0)
Black 0 (0.0)
Body mass index 20 (0.2)
Systolic blood pressure 2 (0.0)
Smoking status 60 (0.5)
Hypertension 44 (0.4)
Diabetes mellitus 47 (0.4)
Composite cardiovascular disease 0 (0.0) Estimated glomerular filtration rate 0 (0.0) Urinary albumin to creatinine ratio 98 (0.9)
C-reactive protein 215 (2.0)
Neighborhood socioeconomic index 245 (2.2)
Annual household income 495 (4.5)
Education level 17 (0.2)
Temperature 0 (0.0)
Supplemental Table 6. Heterogeneity of effect (I
2) for associations of annual average PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD
eGFR I2 (P value) UACR I2 (P value) CKD I2 (P value)
Model 1 58.4% (0.07) 64.1% (0.04) 0.0% (0.56)
Model 2 28.1% (0.24) 50.4% (0.11) 6.8% (0.36)
Model 1: sex, age, race, neighborhood socioeconomic score, family income, education level Model 2: Model 1 + BMI, diabetes mellitus, hypertension, systolic blood pressure, composite cardiovascular disease, cigarette smoking, eGFR,* UACR,** C-reactive protein, temperature Covariate omitted for eGFR analyses (*) and UACR analyses (**). Analyses performed per 1 µg/m3 higher PM2.5.
eGFR, estimated glomerular filtration rate; UACR, urinary albumin to creatinine ratio
Supplemental Table 7. Sensitivity analyses for associations of annual average PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD when omitting Jackson and testing 60- and 120-month PM
2.5exposures
Cross-sectional model participants
eGFR, ml/min/1.73 m2
(95% CI) P value UACR, % difference (95% CI) P value Longitudinal model participants
Incident CKD, HR
(95% CI) P value Jackson omitted
Model 1 8829 -0.06 (-0.34 to 0.22) 0.69 10.5 (7.6 to 13.5) < 0.001 8282 1.07 (1.03 to 1.12) 0.001
Model 2 -0.03 (-0.32 to 0.25) 0.82 7.8 (5.1 to 10.6) < 0.001 1.05 (0.99 to 1.11) 0.08
60-month PM2.5
Model 1 10,893 -0.26 (-0.61 to 0.10) 0.16 4.7 (1.1 to 8.3) 0.009 10,206 1.06 (1.01 to 1.11) 0.03
Model 2 -0.28 (-6.4 to 0.08) 0.12 4.1 (0.5 to 7.7) 0.02 1.06 (0.98 to 1.14) 0.14
120-month PM2.5
Model 1 10,838 -0.24 (-0.61 to 0.12) 0.20 1.8 (-3.7 to 7.7) 0.53 10,151 1.02 (0.96 to 1.07) 0.58
Model 2 -0.27 (-0.64 to 0.10) 0.16 1.8 (-4.2 to 8.2) 0.56 1.01 (0.95 to 1.08) 0.77
Model 1: sex, age, race, neighborhood socioeconomic score, family income, education level.
Model 2: Model 1 + body mass index, diabetes mellitus, hypertension, systolic blood pressure, composite cardiovascular disease, cigarette smoking, eGFR,* UACR,**
C-reactive protein, temperature.
Covariate omitted for eGFR analyses (*) and UACR analyses (**). Analyses performed per 1 µg/m3 higher PM2.5. UACR coefficient exponentiated using the formula (eβ -1)*100%.
CI, confidence interval; eGFR, estimated glomerular filtration rate; HR, hazard ratio; PM2.5, particulate matter less than 2.5 µm in diameter; UACR, urinary albumin to creatinine ratio.
Supplemental Table 8. Heterogeneity of effect for associations of annual average PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD when excluding Jackson
eGFR I2 (P value) UACR I2 (P value) CKD I2 (P value)
Model 1 0.0% (0.78) 0.0% (0.42) 0.0% (0.42)
Model 2 0.0% (0.87) 0.0% (0.45) 32.5% (0.23)
Model 1: sex, age, race, neighborhood socioeconomic score, family income, education level.
Model 2: Model 1 + body mass index, diabetes mellitus, hypertension, systolic blood pressure, composite cardiovascular disease, cigarette smoking, eGFR,* UACR,** C-reactive protein, temperature.
Covariate omitted for eGFR analyses (*) and UACR analyses (**). Analyses performed per 1 µg/m3 higher PM2.5.
eGFR, estimated glomerular filtration rate; UACR, urinary albumin to creatinine ratio.
Supplemental Table 9. CKD incidence in participants with estimated glomerular filtration rate ≥ 60 ml/min/1.73 m
2at baseline by site, stratified by median annual average PM
2.5Forsyth Co. Jackson Minneapolis Washington Co.
Overall 2527 2020 3015 2740
PM2.5 ≤ median 1263 1009 1504 1377
PM2.5 > median 1264 1011 1511 1363
Median years follow up
Overall 17.4 17.0 18.2 17.2
PM2.5 ≤ median 17.7 17.8 18.5 17.8
PM2.5 > median 17.2 16.4 18.1 16.6
Number of CKD events
Overall 642 625 734 815
PM2.5 ≤ median 328 311 358 402
PM2.5 > median 314 314 376 413
Number of CKD events diagnosed at visit
Overall 34 17 23 31
PM2.5 ≤ median 22 8 10 19
PM2.5 > median 12 9 13 12
Number of CKD events diagnosed by ICD code
Overall 608 608 711 784
PM2.5 ≤ median 306 303 348 383
PM2.5 > median 302 305 363 401
Person-years
Overall 38,869 30,366 47,322 41,641
PM2.5 ≤ median 20,029 15,647 23,833 21,476
PM2.5 > median 18,840 14,720 23,489 20,165
CKD incidence per 1000 person-years (95% CI)
Overall 16.5 (15.3 to 17.8) 20.6 (19.0 to 22.3) 15.5 (14.4 to 16.7) 19.6 (18.3 to 21.0)
PM2.5 ≤ median 16.4 (14.7 to 18.2) 19.9 (17.8 to 22.2) 15.0 (13.5 to 16.7) 18.7 (17.0 to 20.6) PM2.5 > median 16.7 (14.9 to 18.6) 21.3 (19.1 to 23.8) 16.0 (14.5 to 17.7) 20.5 (18.6 to 22.6)
Supplemental Table 10. Between and within site effects for Cox proportional hazards models of annual average PM
2.5and incident CKD
Between site Cox model Between and within site Cox model Between site CKD HR (95% CI) 1.06 (1.02 to 1.11) 1.02 (0.99 to 1.04)
Within site CKD HR (95% CI) 1.05 (1.01 to 1.10)
Model 2 used for analysis: Model 1 (sex, age, race, neighborhood socioeconomic score, family income, education level) + body mass index, diabetes mellitus, hypertension, systolic blood pressure, composite cardiovascular disease, cigarette smoking, estimated glomerular filtration rate, urinary albumin to creatinine ratio, C-reactive protein, temperature.
Analyses performed per 1 µg/m3 higher PM2.5. CI, confidence interval; HR, hazard ratio.
Supplemental Table 11. Sensitivity analyses for association of annual average PM
2.5with incident CKD when excluding those with urinary albumin to creatinine ratio ≥ 30 mg/g
Longitudinal model participants Incident CKD, HR (95% CI) P value
Model 1 9496 1.06 (1.02 to 1.11) 0.006
Model 2 1.05 (1.01 to 1.10) 0.02
Model 1: sex, age, race, neighborhood socioeconomic score, family income, education level.
Model 2: Model 1 + body mass index, diabetes mellitus, hypertension, systolic blood pressure, composite cardiovascular disease, cigarette smoking, estimated glomerular filtration rate, UACR, C-reactive protein, temperature.
Analyses performed per 1 µg/m3 higher PM2.5.
eGFR, estimated glomerular filtration rate; UACR, urinary albumin to creatinine ratio.
Supplemental Table 12. Competing risk analysis for association of annual average PM
2.5with incident CKD with a competing risk of non-CKD death
Incident CKD, HR (95% CI) P value
Model 1 1.04 (1.00* to 1.08) 0.045
Model 2 1.02 (0.98 to 1.07) 0.33
Model 1: sex, age, race, neighborhood socioeconomic score, family income, education level.
Model 2: Model 1 + body mass index, diabetes mellitus, hypertension, systolic blood pressure, composite cardiovascular disease, cigarette smoking, estimated glomerular filtration rate, urinary albumin to creatinine ratio, C-reactive protein, temperature.
Analyses performed per 1 µg/m3 higher PM2.5. Of 10,302 baseline participants at visit 4, 7450 and 6725 were alive at visits 5 and 6, respectively.
* Lower confidence interval of 1.001.
CI, confidence interval; HR, hazard ratio.
Supplemental Table 13. Positive and negative control models for the associations of annual average PM
2.5with height, area deprivation index, incident cellulitis, and incident mortality
Negative controls Positive controls
Linear regression models Height (cm) P value Area deprivation index P value Model 1, change (95% CI) -0.02 (-0.16 to 0.12) 0.80 0.61 (0.04 to 1.18) 0.04 Model 2, change (95% CI) -0.03 (-0.20 to 0.14) 0.73 0.67 (0.11 to 1.23) 0.02 Cox proportional hazards models Cellulitis P value Mortality P value
Events (N) 659 4277
Model 1, HR (95% CI) 1.03 (0.90 to 1.17) 0.68 1.04 (1.01 to 1.08) 0.01 Model 2, HR (95% CI) 1.00 (0.88 to 1.13) 0.97 1.04 (1.00§ to 1.07) 0.04 Model 1: sex, age, race, neighborhood socioeconomic score,* family income,* education level*.
Model 2: Model 1 + body mass index, diabetes mellitus, hypertension, systolic blood pressure, composite cardiovascular disease, cigarette smoking, C-reactive protein, temperature.
Covariate omitted for area deprivation index analyses (*). Analyses performed per 1 µg/m3 higher PM2.5.
§ Lower confidence interval of 1.002.
CI, confidence interval; HR, hazard ratio.
Supplemental Figure 1. Forest plots describing overall and site-specific associations of annual average PM
2.5with baseline estimated glomerular filtration rate, urinary albumin to creatinine ratio, and incident CKD. Model 1 includes sex, age, race, neighborhood
socioeconomic score, family income, education level. Model 2 includes Model 1 + body mass index, diabetes mellitus, hypertension, systolic
blood pressure, composite cardiovascular disease, cigarette smoking, eGFR,* UACR,** C-reactive protein, temperature. Covariate omitted for
eGFR analyses (*) and UACR analyses (**). Co, county; eGFR, estimated glomerular filtration rate; PM
2.5, particulate matter less than 2.5 µm in
diameter; UACR, urinary albumin to creatinine ratio.
Supplemental Figure 2. Forest plots describing overall and site-specific associations of 60-month PM
2.5with baseline estimated glomerular
filtration rate, urinary albumin to creatinine ratio, and incident CKD. Model 1 includes sex, age, race, neighborhood socioeconomic score,
family income, education level. Model 2 includes Model 1 + body mass index, diabetes mellitus, hypertension, systolic blood pressure, composite
cardiovascular disease, cigarette smoking, eGFR,* UACR,** C-reactive protein, temperature. Covariate omitted for eGFR analyses (*) and UACR
analyses (**). Co, county; eGFR, estimated glomerular filtration rate; PM
2.5, particulate matter less than 2.5 µm in diameter; UACR, urinary
albumin to creatinine ratio.
Supplemental Figure 3. Forest plots describing overall and site-specific associations of 120-month PM
2.5with baseline estimated glomerular
filtration rate, urinary albumin to creatinine ratio, and incident CKD. Model 1 includes sex, age, race, neighborhood socioeconomic score,
family income, education level. Model 2 includes Model 1 + body mass index, diabetes mellitus, hypertension, systolic blood pressure, composite
cardiovascular disease, cigarette smoking, eGFR,* UACR,** C-reactive protein, temperature. Covariate omitted for eGFR analyses (*) and UACR
analyses (**). Co, county; eGFR, estimated glomerular filtration rate; PM
2.5, particulate matter less than 2.5 µm in diameter; UACR, urinary
albumin to creatinine ratio.